Targeting newly discovered oxygen-sensing cascades for novel cancer treatments Biology, equipment, drug candidates (EUROXY)
Third Party Funds Group - Sub project
Acronym: EUROXY
Start date : 01.01.2005
End date : 30.06.2010
Aalborg University
Denmark (DK)
Albert-Ludwigs-Universität Freiburg
Germany (DE)
AstraZeneca UK Limited
United Kingdom (GB)
Charité - Universitätsmedizin Berlin
Germany (DE)
Deutsches Herzzentrum München
Germany (DE)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Institute of Biotechnology
Lithuania (LT)
Jobst Technologies GmbH
Germany (DE)
Karolinska Institute
Sweden (SE)
LEA Medizintechnik GmbH
Germany (DE)
Denmark (DK)
Albert-Ludwigs-Universität Freiburg
Germany (DE)
AstraZeneca UK Limited
United Kingdom (GB)
Charité - Universitätsmedizin Berlin
Germany (DE)
Deutsches Herzzentrum München
Germany (DE)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Institute of Biotechnology
Lithuania (LT)
Jobst Technologies GmbH
Germany (DE)
Karolinska Institute
Sweden (SE)
LEA Medizintechnik GmbH
Germany (DE)